These followed two deals late last week – on Thursday GSK made an $85 million licensing agreement with Surface Oncology for an early-stage antibody asset, which adds a natural killer cell ...

Sales of GSK (NYSE:GSK) and Pfizer’s (NYSE:PFE) RSV vaccines have reportedly fallen since U.S. regulators narrowed the ...

NEW YORK (Reuters) - Drugmakers including Pfizer Inc <PFE.N>, GlaxoSmithKline PLC <GSK.L ... is running for re-election in 2020. Many branded drugmakers have pledged to keep their US list price ...

Law Offices of Howard G. Smith reminds investors of the upcoming April 7, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased GSK plc. ("GSK" or the ...